While physicians strive to set realistic expectations for patients undergoing knee and hip joint replacements, a new study reveals that doctor and patient expectations are sometimes not aligned… Read The Full Article…Differing Patient And Doctor Expectations From Joint Replacement Surgeries Read more »

Approximately 21 million visits were made to physicians’ offices due to back problems in 2006. While countless adults experience back pain and stiffness, many suffer from serious spine and back conditions – including injury, herniated discs and the deterioration of the vertebrae… Read The Full Article…Breakthroughs In Treatment Of Spine And Back Conditions Read more »

Electromagnetic pulses significantly decrease pain and inflammation associated with osteoarthritis of the knee, according to Henry Ford Hospital researchers… Read The Full Article…Pain Relief For Osteoarthritis Provided By Electromagnetic Pulses Read more »

NICE’s independent appraisal committee has asked Roche, the manufacturer of tocilizumab (RoActemra), a new treatment for moderate to severe active rheumatoid arthritis, for further additional information on its product… Read The Full Article…NICE Asks For More Data On New Drug For Rheumatoid Arthritis Read more »

The National Rheumatoid Arthritis Society (NRAS) has expressed their frustration at NICE’s provisional decision not to allow patients with rheumatoid arthritis to routinely switch from one Anti-TNF drug to another. This is the second time NICE has appraised the sequential effectiveness of multiple biologic therapies following NRAS’s successful appeal of negative NICE guidance on switching [...] Read more »

Today the Arthritis and Musculoskeletal Alliance (ARMA), backed by leading policymakers and employers, is calling for positive action to ensure people with musculoskeletal disorders (MSDs) are properly supported to access employment and remain in their jobs… Read The Full Article…New ‘Work Charter’ Launched To Help 6.5m People With Musculoskeletal Conditions To Stay In Work, UK Read more »

The National Institute for Health and Clinical Excellence (NICE) is currently appraising a number of drugs as possible treatments for rheumatoid arthritis after treatment with a tumour necrosis factor (TNF) inhibitor has failed. This is a part review of NICE technology appraisal guidance 36, and a review of NICE technology appraisal guidance 126 [...] Read more »

BioTrends Research Group released topline findings from LaunchTrends®: ACTEMRA, Wave 1, highlighting the market uptake of the product at one month post launch. Actemra (tocilizumab), marketed by Roche-Genentech, is a new IL-6 inhibitor with monthly dosing by IV infusion. The study results are based on an on-line survey completed by 77 rheumatologists in [...] Read more »

New research has identified four aspects of immune system disturbance which lead to the development of coeliac disease. Nearly 40 different inherited risk factors which predispose to the disease have now been identified… Read The Full Article…Celiac Disease: Pinpointing Immune System Disturbances Read more »

A new study found that fluoxetine (Prozac®) and citalopram (Celexa®) treatment significantly inhibited disease progression of collagen-induced arthritis (CIA) in mice. Research led by Sandra Sacre, Ph.D… Read The Full Article…SSRIs Offer Model For Drug Development Opportunities To Treat Rheumatoid Arthritis Read more »